Dermata Therapeutics, Inc. (DRMA)
1.21
-0.02
(-1.63%)
USD |
NASDAQ |
Sep 04, 16:00
1.24
+0.03
(+2.48%)
After-Hours: 20:00
Dermata Therapeutics Net Income (Quarterly) : -2.967M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.967M |
| March 31, 2026 | -1.848M |
| December 31, 2025 | -1.862M |
| September 30, 2025 | -1.692M |
| June 30, 2025 | -1.701M |
| March 31, 2025 | -2.304M |
| December 31, 2024 | -3.151M |
| September 30, 2024 | -3.173M |
| June 30, 2024 | -2.829M |
| March 31, 2024 | -3.134M |
| December 31, 2023 | -2.134M |
| September 30, 2023 | -1.719M |
| June 30, 2023 | -1.701M |
| Date | Value |
|---|---|
| March 31, 2023 | -2.240M |
| December 31, 2022 | -1.670M |
| September 30, 2022 | -2.425M |
| June 30, 2022 | -2.731M |
| March 31, 2022 | -2.786M |
| December 31, 2021 | -2.553M |
| September 30, 2021 | -1.713M |
| June 30, 2021 | -1.332M |
| March 31, 2021 | -2.305M |
| September 30, 2020 | -0.5974M |
| June 30, 2020 | -0.8216M |
| March 31, 2020 | -1.421M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 3.309M |
| Perspective Therapeutics, Inc. | -26.98M |
| MiMedx Group, Inc. | -14.84M |
| ABVC BioPharma, Inc. | -0.8105M |
| Endonovo Therapeutics, Inc. | -0.5884M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 2.967M |
| EPS Diluted (Quarterly) | -0.7377 |
| Enterprise Value | 0.4539M |
| Earnings Yield | -362.5% |
| Normalized Earnings Yield | -362.51 |